Samsung Bio inks US contract manufacturing deal worth $1.3B
Despite persistent uncertainty under the Trump administration’s international trade policy, Korea’s Samsung Biologics continues to snare billion-dollar contract…
Samsung Biologics pays GSK $280M to secure first US manufacturing site
Already boasting an outsized presence in its home country of South Korea, CDMO juggernaut Samsung Biologics is making…
SK strikes settlement with MSN over future Xcopri generic: reports
For the first time, SK Biopharmaceuticals has struck a settlement with a generics manufacturer who has applied for…
Contractor SK Pharmteco heralds completion of 2 API plants in Ireland
The summer of the high-potency active pharmaceutical ingredient (HPAPI) expansion continues, as yet another manufacturing specialist makes inroads…
Fierce Pharma Asia—Trump’s generic drug tariffs; Samsung Bio’s $1.8B acquisition; An unusual IPO
Generic drugmakers will face import tariffs in the U.S., President Donald Trump announced this week. Samsung Biologics is…
Samsung Bio ekes ahead of Korea biopharma peers with stellar 2025
As Samsung Biologics’ contract manufacturing business continues to fire on all cylinders, the CDMO has earned a unique…
Samsung Biologics faces threat of strike action in Korea
High-flying Samsung Biologics is facing a rare bit of public turbulence after the CDMO’s labor union secured the…
Union strike looms at Samsung Bio amid massive revenue growth
Samsung Bio is bringing its financial hot streak into 2026, with no signs of stopping—save for a potential…
Korea’s LOTTE Biologics expands antibody manufacturing deal with Ottimo Pharma
Korea’s LOTTE Biologics expands antibody manufacturing deal with Ottimo Pharma May 18, 2026 | Monday | News Building…
Korea’s LOTTE Biologics expands antibody manufacturing agreement with Ottimo Pharma
Korea’s LOTTE Biologics expands antibody manufacturing agreement with Ottimo Pharma May 18, 2026 | Monday | News Building…
Samsung BioLogics lands $1.3 billion U.S. contract amid tariff uncertainty
1. $1.3 billion contract through 2029 makes this one of Samsung BioLogics’ largest agreements.2. Expansion plans to nearly…
Basel Area Business & Innovation inks new collaboration with Korean biopharma companies
Basel Area Business & Innovation inks new collaboration with Korean biopharma companies May 6, 2026 | Wednesday |…